Background. Dynamic variables, for example, systolic pressure variation (SPV), are superior to filling pressures for assessing fluid responsiveness. We analysed the effects of SPV-guided intraoperative fluid management on organ function and perfusion when compared with routine care.
Major abdominal surgery is associated with a risk of hypovolaemia which may cause organ dysfunction, increased postoperative morbidity, and death. 1 2 Goal-directed fluid management during the intraoperative period has been found to be associated with improved outcome and reduction in hospital stay in patients undergoing cardiac and major orthopaedic surgery. 3 -5 The hepato-splanchnic tract is considered to be an early warning system ('canary of the body') and plays an important role in the development of sepsis and multiple organ failure. 6 As a consequence, optimization and maintenance of hepato- volume optimization. However, it is still a matter of debate which indicator of cardiac preload should be clinically used for optimizing cardiac preload, and central venous pressure (CVP) is widely used during major abdominal surgery. However, CVP as a static preload variable has its limitations 7 and systolic pressure variation (SPV) 8 as marker of fluid responsiveness has been shown to be superior to cardiac filling pressures. 9 10 Gan and colleagues 11 reported that intraoperative optimization of volume status by an oesophageal Doppler-based algorithm positively influenced postoperative morbidity and mortality. Most recently, and with respect to assessment of fluid responsiveness by dynamic variables, Lopes and colleagues 12 reported that monitoring and minimizing pulse pressure variation (PPV) by volume loading during highrisk surgery improves postoperative outcome and decreases length of hospital stay. In this study, we studied whether goal-directed intraoperative fluid management using SPV as an infusion trigger in patients undergoing major abdominal surgery would maintain stability of global and hepato-splanchnic perfusion thereby leading to a reduction in postoperative ICU length of stay and mortality.
Methods
The study had approval from the institutional ethics board and written informed patient consent was obtained. Between September 2002 and March 2003, we enrolled 80 patients, American Society of Anesthesiologists (ASA) class I -III. All patients were undergoing elective major abdominal general or gynaecologic surgery with bowel resection and an anticipated blood loss of .500 ml. Exclusion criteria were: age ,18 yr, emergency surgery, coagulopathy, renal and hepatic dysfunction, hyperthyroidism (because indocyanine green used in this study contains iodine), and cardiac rhythm other than sinus rhythm. All patients received midazolam p.o. (3.7527.5 mg) on the evening before and before anaesthesia. All patients underwent central venous (triple lumen catheter, Certofix Trio, Braun Melsungen, Germany) and arterial catheterization (A. radialis, 20 G, BD Medical Systems, Swindon, UK) after induction of anaesthesia. Since no arterial thermistor catheter was used, no transpulmonary thermodilution cardiac output was obtained. We decided not to place such a catheter, since it is not standard care in our department for those patients. CVP was monitored continuously using a patient monitor system (Datex AS3 , was given as individually required. Ventilation was adjusted to maintain arterial carbon dioxide partial pressure at 4.7-5.3 kPa, and temperature was maintained at .358C throughout surgery. In all patients, end-expiratory pressure (PEEP) was kept at a level of 5 cm H 2 O, the I:E ratio was 1:1, and tidal volume was set at 8 ml kg 21 . If an epidural catheter was placed before operation for postoperative pain management, a 3 ml test dose consisting of lidocaine 1.5% with 1:200 000 epinephrine was administered. Subsequent epidural local anaesthetic drugs were started at the end of surgery. Postoperative analgesia was provided by either epidural (ropivacaine 0.125% and fentanyl 0.001%) or patient-controlled analgesia with pirinitramide. Anaesthesia was maintained at a constant level as judged by standard clinical criteria. All cardiovascular variables and urinary flow were monitored and recorded during anaesthesia. Types and volumes of all fluids administered intraoperatively (including but not limited to colloid and crystalloid solutions, blood, and blood products) were recorded, as were the volumes and doses of any drugs given during anaesthesia. For infusion management, a crystalloid solution (E153, Serumwerk Bernburg AG, Bernburg, Germany) (Na þ 140 mmol litre Influence of SPV-guided intraoperative fluid management choice of fluid was made by the anaesthesiologist. When considered necessary, norepinephrine (the only 'vasopressor' used in our department) was administered to maintain mean arterial pressure .70 mm Hg.
Before surgery, patients were randomized into either the protocol (SPV) or control (CON) groups using sealed envelopes. SPV and SVV data were visible to the anaesthesia team for patients in the SPV group whereas the team were blinded to these data for patients in the control group. Recording of SPV and SVV was finished at the end of surgery. In the SPV group, fluid treatment was guided by SPV which was kept ,10%. The control group received usual care.
The protocol called for the administration of blood products (red blood cells, platelets, and fresh frozen plasma) when clinically indicated and supported by laboratory evidence of a haematocrit ,23% or abnormal coagulation ( platelet count ,100 000 litre 21 , prothrombin time .1.5 times control, or activated partial thromboplastin time .1.5 times control).
The objectives of our study were to analyse the effects on SPV-guided treatment on oxygen transport and regional perfusion. Samples for determination of central venous oxygen saturation (ScvO 2 ), serum lactate, bilirubin, and creatinine were taken after induction of anaesthesia, after 3, 6, 12, 18, and 24 h. As an indicator of hepato-splanchnic blood flow, we measured the indocyanine green plasma disappearance rate (ICG-PDR). 13 We have previously shown that ICG-PDR, which is a marker of hepatic blood flow and function, can be obtained reliably non-invasively by a transcutaneous system in critically ill patients.
14 ICG-PDR was measured by a finger clip system (LiMON TM , Pulsion Medical Systems, Munich, Germany). For each measurement, 0.5 mg kg 21 ICG (Pulsion Medical Systems) was injected into a central vein. Gastric mucosal PCO 2 tension was measured continuously by a gas tonometric catheter which was advanced into the stomach immediately after induction of anaesthesia (Tonometrics catheter, Tono-14F, Datex-Ohmeda). 15 As a measure of gastric mucosal perfusion, we calculated the difference between gastric mucosal and end-tidal CO 2 tension ('PCO 2 -gap'). During the measurement, ventilator settings and dosages of vasoactive drugs remained unchanged. The ScvO 2 , ICG-PDR, and PCO 2 -gap were not available to the clinical team.
After operation, all patients were transferred to the ICU while mechanically ventilated and extubated when they fulfilled standard clinical criteria. Length of ICU and hospital stay and outcome were recorded.
Statistical analysis
Patient characteristic data are presented as median and range. Groups were compared using x 2 and Wilcoxon tests. Organ function variables, variables of global O 2 transport, and vasoactive drug support were compared by one-way ANOVA on ranks for repeated measurements with an all pairwise comparison method (Student -NewmanKeuls procedure). P,0.05 was considered statistically significant. For the statistical analysis, SigmaStat for Windows TM (version 1.0) was used.
Results
Patient characteristics are summarized in Table 1 . Both groups were comparable with regard to most variables. Patients in the SPV-guided group tended to receive more fluid. Duration of mechanical ventilation, length of ICU and hospital stay, and mortality were comparable between both groups. One patient in the control group had severe bleeding complications, required operative revision, and developed multiple organ failure from which the patient finally died after several weeks. In contrast, all patients in the SPV group were discharged from the ICU alive. No patient developed arrhythmias and nobody experienced adverse events after ICG injections.
Heart rate significantly varied but not between corresponding time points whereas arterial blood pressure during operation was comparable throughout between groups (Table 2) . However, at 3 and 6 h after induction of anaesthesia, there was a significant increase in SPV (P¼0.04 and P¼0.01) and Ddown (P¼0.005 and P¼0.01) in the control group, suggesting hypovolaemia at these time points when compared with the SPV group. Variables of oxygen transport and organ function at the corresponding time points were not different between both groups (Table 3 ). Baseline and 24 h values for ICG-PDR: 28.5 (7.9) and 22.7 (7.8) vs 23.9 (6.9) and 26.1 (5.9)% min 21 ( Fig. 1) , 77.7 (6.6) and 72.6 (5.5) vs 79.3 (7.1) and 72.8 (6.7) % for ScvO 2 and 1.0 (0.4) and 1.2 (0.6) vs 0.9 (0.2) and 1.3 (0.5) mmol litre 21 for lactate. Furthermore, bilirubin and creatinine significantly increased after 24 h in both groups. Finally, norepinephrine requirements transiently increased at 3 h in both groups.
Discussion
In this study, we found that intraoperative SPV-guided therapy was associated with slightly increased fluid administration whereas organ perfusion was not different when compared with routine care. In detail, global O 2 transport and organ function and perfusion were comparable between both groups.
In general, previous studies that compared different managements for i.v. fluid administration demonstrated no difference in the endpoints if there is not enough difference in the amount of fluid administered between the groups. Our study is in line and confirms these results insofar as our groups were also not significantly different. However, in other studies, average differences of only 565, 11 650, 16 or 625 ml, 17 for example, did improve the results in the goal-directed groups. Notably, volume differences are in the same range as ours (535 ml more fluid in the SPV group). For instance, Gan and colleagues 11 reported that intraoperative plasma volume expansion guided by oesophageal Doppler led to an earlier return of bowel function, lower incidence of postoperative nausea and vomiting, and decrease in length of postoperative hospital stay. In this study, significantly more colloid was infused in the protocol group. Conway and colleagues 16 found that fluid titration using oesophageal Doppler during bowel surgery can improve haemodynamic parameters (i.e. cardiac output) and may reduce critical care admissions after operation. In cardiac surgical patients, McKendry and colleagues 17 reported fewer postoperative complications, a significantly lower usage of intensive care beds and a shorter duration of hospital stay in the protocol group. Wakeling and colleagues 18 reported that intraoperative oesophageal Doppler-guided fluid management was associated with a reduction in gut dysfunction, overall morbidity, and postoperative hospital stay. Patients in the protocol group received significantly more colloids (median 2000 vs 1500 ml), but the range of colloid given in the treatment group was large, that is, 50025000 ml. Oesophageal Doppler which requires practice for adequate use 19 was used in all these previous studies. To explain the differences between the abovementioned results and our findings, one may speculate that SPV is not sensitive enough to guide the administration of fluid. It is not clear Table 2 Results for intraoperative global haemodynamics, CVP, and haemoglobin content. The number of patients at each time point is given in brackets (n). Data are median (25th -75th percentiles). HR, heart rate; BPsys, systolic arterial blood pressure; MAP, mean arterial blood pressure; BPdia, diastolic arterial blood pressure; SPV, systolic pressure variation; Ddown, negative component of SPV; Dup, positive component of SPV; SVV, stroke volume variation; CVP, central venous pressure. Comparison by one-way ANOVA on ranks for repeated measurements with an all pairwise comparison method (Student -Newman -Keuls procedure). P,0.05 was considered statistically significant. Only significances between the groups at the same time point are reported. *Significantly different from SPV (P¼0.04) and Ddown (P¼0.005) at 3 h in the SPV group. † Significantly different from SPV (P¼0.01) and Ddown (P¼0.01) at 6 h in the SPV group Influence of SPV-guided intraoperative fluid management if full PiCCO TM technology would have been a more sensitive marker. By using transpulmonary thermodilutionderived variables (global end-diastolic volume, extravascular lung water) for guiding fluid treatment, Goepfert and colleagues 20 recently reported less use of vasoactives (norepinephrine and epinephrine) and potentially earlier readiness for discharge from the ICU in cardiac surgical patients. In general, SPV and PPV both have a higher specificity and sensitivity for prediction of a positive reaction (increase in cardiac output by fluid challenge) when compared with cardiac filling pressures. In a small randomized trial, Lopes and colleagues 12 found that monitoring and minimizing PPV by volume loading during high-risk surgery improved postoperative outcome, decreased duration of mechanical ventilation, and the length of stay in hospital. The PPV group received more fluids and transiently had lower serum lactate values. In our study, we did not assess PPV but SVV which has been shown to be correlated with SPV. 21 Flow autoregulation in the splanchnic bed maintains the perfusion constant, despite variations in circulating volume. 22 In anaesthetized pigs, 22 effects of low (3 ml kg 21 h 21 ), medium (7 ml kg 21 h 21 ) or high (20 ml kg 21 h 21 ) fluid volumes were compared. The three volume regimens tested did not have different effects on tissue oxygen pressure in the gut, suggesting efficient autoregulation of intestinal blood flow in healthy subjects undergoing uncomplicated abdominal surgery. ScvO 2 which in abdominal surgical patients shows significant fluctuations in the immediate postoperative period that are not always associated with changes in oxygen delivery, suggesting that oxygen consumption is also an important determinant of ScvO 2 . 23 Reductions in ScvO 2 were found to be independently associated with postoperative complications: ScvO 2 was 63.4 (10.4)% in patients with complications vs 67.1 (7.7) % in patients without complications. 23 Noteworthy, we found a significant decrease in ScvO 2 between baseline and 24 h which was not different between the groups whereas values after 24 h were higher than those reported by Pearse and colleagues. 23 Finally, patients in the control group transiently required slightly more norepinephrine (3 h), but this seemed not to have negatively influenced global and regional perfusion.
Our study suffers from several limitations. Since all patients studied routinely only underwent peripheral arterial cannulation and no extended haemodynamic monitoring, no cardiac output values are available in this study. Furthermore, the number of patients in this single centre study was intended to study effects on global and regional variables and does not allow us to draw conclusions with respect to 'hard' criteria such as length of ICU or hospital stay or even mortality. Finally, we studied relatively healthy patients as is clear from the normal ScvO 2 , PCO 2 -gap, 24 and lactate levels. Probably, results may be different in more severely ill patients in whom transient hypovolaemia may have more impact on organ dysfunction and length of ICU stay.
In conclusion, SPV-guided treatment was associated with slightly more intraoperative fluid whereas organ perfusion and function was similar when compared with routine care.
